Review: Bovine foetal mortality - risk factors, causes, immune responses and immuno-prophylaxis.
| Autor: | Mee JF; Teagasc, Moorepark Research Centre, Animal and Bioscience Research Department, Fermoy P61P302, Ireland. Electronic address: john.mee@teagasc.ie., Hayes C; Department of Agriculture, Food and the Marine, Model Farm Road, Cork, Ireland., Stefaniak T; Department of Immunology, Pathophysiology and Veterinary Preventive Medicine, Wroclaw University of Environmental and Life Sciences, 50-375 Wrocław, Poland., Jawor P; Department of Immunology, Pathophysiology and Veterinary Preventive Medicine, Wroclaw University of Environmental and Life Sciences, 50-375 Wrocław, Poland. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Animal : an international journal of animal bioscience [Animal] 2023 May; Vol. 17 Suppl 1, pp. 100774. |
| DOI: | 10.1016/j.animal.2023.100774 |
| Abstrakt: | This review of bovine foetal mortality (>42 d gestation) concluded that while the majority of risk factors associated with sporadic loss operate at animal-level, e.g. foetal plurality, those that operate at herd-level, e.g. some foetopathogenic infections, are more likely to result in abortion outbreaks. While the causes of foetal mortality have traditionally been classified as infectious and non-infectious, in fact, the latter category is a diagnosis of exclusion, generally without determination of the non-infectious cause. This review has also established that the traditional dichotomisation of infectious agents into primary and secondary pathogens is based on a flawed premise and these terms should be discontinued. The delicate balance of the maternal gestational immune system between not rejecting the allograft (conceptus) but rejecting (attacking) foetopathogens is stage-of-pregnancy-dependent thus the timing of infection determines the clinical outcome which may result in persistent infection or foetal mortality. Utilisation of our knowledge of the materno-foetal immune responses to foetopathogenic infection has resulted in the development of numerous mono- and polyvalent vaccines for metaphylactic or prophylactic control of bovine foetal mortality. While some of these have been shown to significantly contribute to reducing the risk of both infection and foetal mortality, others have insufficient, or conflicting evidence, on efficacy. However, recent developments in vaccinology, in particular the development of subunit vaccines and those that stimulate local genital tract immunity, show greater promise. (Copyright © 2023 The Author(s). Published by Elsevier B.V. All rights reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|